TOP TIERMARKET NEWSWIRE
News & sentiment

ELOXX PHARMACEUTICAL (ELOX) — News & AI sentiment

ELOXX PHARMACEUTICAL (ELOX) news roundup. 3 stories in the past week, 5 over 30 days. Average 30-day sentiment is 55.2/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 51.3/100
30d stories
5
avg sentiment 55.2/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ELOX news in the last 24 hours, 7 days, 30 days and 90 days

How much ELOX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowELOX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days351.3/100ELOX headlines →
Last 30 days555.2/100ELOX headlines →
Last 90 days1150.7/100ELOX headlines →

Latest stories on ELOX

2d ago
2d ago
2d ago
Lucid Capital Markets initiates Eloxx Pharma stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 20
Aug 20
Aug 12
Eloxx Pharmaceuticals GAAP EPS of -$0.66
Seeking Alpha28 · bearishearnings
Aug 11
Aug 11
Guggenheim initiates Eloxx Pharma stock with buy on kidney data
Investing.com Analyst Ratings61 · neutralanalyst
Jul 20
Jul 14
Jul 1
Jun 9
Jun 9
Jun 1
Open ELOX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →